Tahir Misbah 4
4 · Maze Therapeutics, Inc. · Filed Sep 2, 2025
Insider Transaction Report
Form 4
Tahir Misbah
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-09-02+325,000→ 325,000 totalExercise: $15.32Exp: 2035-09-01→ Common Stock (325,000 underlying)
Footnotes (1)
- [F1]The option shall vest as to 1/4th of the total award on September 2, 2026, and thereafter shall vest as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.